Analyst Update: 3D Systems Corporation, Cara Therapeutics Inc, and Viacom, Inc.

Analysts are weighing in on 3D Systems Corporation (NYSE:DDD), Cara Therapeutics Inc (NASDAQ:CARA), and Viacom, Inc. (NASDAQ:VIAB)

Oct 13, 2016 at 1:50 PM
facebook twitter linkedin


Analysts are weighing in on 3-D printing stock 3D Systems Corporation (NYSE:DDD), biotech Cara Therapeutics Inc (NASDAQ:CARA), and media concern Viacom, Inc. (NASDAQ:VIAB). Here's a quick roundup of today's brokerage notes on DDD, CARA, and VIAB.

  • DDD is down 5.5% at $14.79, after Piper Jaffray reiterated its "underweight" evaluation and $10.50 price target. The brokerage firm cited an "extremely discouraging" survey, which suggested a tough third quarter for the company. Despite its recent pullback, 3D Systems Corporation's long-term trend is to the upside, and with a series of higher highs and lows in place from recent months, the shares boast a 70% year-to-date lead. These gains have done little to deter DDD short sellers, however, who currently control 26% of the stock's float. 
  • CARA is moving higher today on the heels of a bullish note from H.C. Wainwright. Specifically, the brokerage firm initiated coverage with a "buy" rating and a $20 price target, waxing optimistic about the drugmaker's treatment for acute pain. The price target represents almost 150% upside to current levels, and territory not seen in over a year for Cara Therapeutics Inc, which is perched 6.3% higher at $8.04. Other analysts already share a bullish outlook, with all four covering brokerage firms handing out "strong buy" recommendations. 

  • A pair of upgrades has VIAB up 1.8% at $35.74. On top of an upgrade to "market perform" from "underperform" at Wells Fargo, the stock was raised to "buy" from "underperform" at BofA-Merrill Lynch, which also raised its price target by $7 to $44 -- which perfectly aligns with the stock's average 12-month price target. The latter firm cited Viacom, Inc.'s low valuation and M&A prospects as reasons to be hopeful -- though the analysts admitted a turnaround was not a sure thing. What is for sure is that VIAB has been lackluster on the charts this year, down 13%, with multiple breakout attempts thwarted by the $46 level. 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Schaeffer's Daily Bulletin Offer
 


 


 
Special Offers from Schaeffer's Trading Partners